October 09, 2026 — RNews

#pharmacodynamics — Friday, October 09, 2026 (1 items)

hot top new

← prev day next day →

20

The conformation-selective PI3Kdelta inhibitor roginolisib in patients with advanced or metastatic cancer, including metastatic uveal melanoma: first-in-human clinical trial. (nature.com)

Di Giacomo AM … Maio M Nature Communications 2026-10-09

#clinical trial #immunotherapy #melanoma #kinase inhibitor #pharmacodynamics